Ramping Up COVID-19 Vaccine Fill and Finish Capacity

SourceContract Pharma
Date Published11/03/2020
Author NameKristin Brooks
Mentions specific company case(s) of reshoring, kept from offshoring, or transplantYes

Additional Reshoring Information:

Company/Division name Grand River Aseptic Manufacturing (GRAM)
Type of work Manufacturing
Reshoring category:Reshoring
Year reshoring announced:2020
Year reshoring implemented or to be implemented:2020
Domestically, the work will be done:In-house
City reshored to:Grand Rapids
State(s) reshored to:MI
If relevant, work nearshored to:-
Product(s) reshoredSARS-CoV-2 vaccine, therapeutics, fill and finish
What domestic positive factors made reshoring more attractive?Government Incentives, Impact on domestic economy, Lead time/Time to market, Proximity to customers/market, Skilled workforce availability/training, Other, Covid-19
Find Reshoring Articles